News Japanese health ministry approves Pfizer’s COVID-19 oral treatment drug
The drug, paxlovid, is to be used for the treatment of mild-to-moderate COVID-19 in people 12 and older and who are at high risk of ...
Osamu Tsukimori
News News The ‘stealth’ subvariant of omicron is spreading in Japan. What impact could it have?
A look at the two known types of the omicron variant and what BA.2's spread could mean for the nation's health care system.
News Japan’s booster rollout is relying on Pfizer and Moderna. How do the shots compare?
Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as eligible, no ...
News Japan scrambles to speed up slowest booster rollout among developed nations
Less than 4% of all residents have received their booster, with the rollout stymied by initial plans for an eight-month shot interval and a seeming ...
News Omicron has fueled a rapid COVID surge in Japan. Still, the endgame may be in sight.
Some experts are optimistic that more treatment options, a high vaccination rate and and a so-far lower mortality rate could herald a transition from pandemic ...